Skip to the content

FDA Medical Device Recalls (openFDA)

DePuy Mitek, Inc., a Johnson & Johnson Co.: Healix Knotless ADV BR 5.5 Suture Anchor

Recall number
Z-0666-2020
Recalling firm
DePuy Mitek, Inc., a Johnson & Johnson Co.
Product
Healix Knotless ADV BR 5.5 Suture Anchor
Status
Terminated
Initiated
2019-11-04
Posted
not on file
Terminated
2020-05-05
Reason
Specific product codes and lots of the Mitek HEALIX ADVANCE" Knotless Anchors were manufactured with BIOCRYL" Biocomposite Material instead of BIOCRYL RAPIDE Biocomposite Material. BIOCRYL and BIOCRYL RAPIDE are biocompatible and effective material choices for absorbable, injection-molded sports medicine implant fixation.
Root cause
Employee error
Action
On November 4, 2019 the firm distributed Urgent Medical Device Recall Communication letters by mail: URGENT FIELD SAFETY NOTICE PRODUCT RECALL HEALIX ADVANCE" Knotless Anchors Dear Valued Customer, On 04-November-2019, DePuy Mitek, Inc. initiated a Voluntary Product Removal of specific product codes and lots of the Mitek HEALIX ADVANCE" Knotless Anchors. The anchors were manufactured with BIOCRYL" Biocomposite Material instead of BIOCRYL RAPIDE Biocomposite Material. BIOCRYL and BIOCRYL RAPIDE are biocompatible and effective material choices for absorbable, injection-molded sports medicine implant fixation. No complaints or adverse events related to this issue have been received for the affected product codes/lots. Product Code: 222330 Product Description: HEALIX KNOTLESS ADV BR 4.75 GTIN: 10886705023462 Lot Number: 5L45257 Product Code: 222331 Product Description: HEALIX KNOTLESS ADV BR 5.5 GTIN: 10886705023479 Lot Numbers: 5L13543 and 5L45259 Potential Harms: Based on the analysis, it is expected that sport medicine implants made from BIOCRYL (PLLA+TCP) would perform equal to those made from BIOCRYL RAPIDE (PLGA + TCP) during the surgery and therapeutic healing period. As such, this product issue presents no foreseeable increased risk to patient safety nor does it alter the product benefit-risk profile. BIOCRYL and BIOCRYL RAPIDE Comparison: " Each material is used clinically today, but in different DePuy Mitek implant brands; both materials have a more than 15 years of use in clinical applications. BIOCRYL was first launched in 2002 and BIOCRYL RAPIDE in 2004. " The mechanical properties (strength, stiffness) of BIOCRYL and BIOCRYL RAPIDE are similar at the time of anchor deployment; BIOCRYL offers equivalent in vitro strength retention during the therapeutic healing period and out to 12 weeks. " As for long-term absorption rates, BIOCRYL RAPIDE is expected to absorb in approximately two years versus approximately four years
Quantity
599
Distribution
US: AL AZ CA CT FL IA IL IN LA MA MD ME MI MN MT NC NE NH NJ NM OH OK OR PA TN TX VA WA WI International: Belgium, Chile, China, Czech Republic, France, India, Japan, Korea, Latvia, New Zealand, Slovakia Sweden
Lot, serial or model codes
Part Number: 222331 Batch/Lot: 5L45259, 5L13543 GTIN: 10886705023479
510(k) numbers
["K130917"]
PMA numbers
not on file
Product code
MAI
Firm FEI
1221934
Firm city
Norwood
Firm state
MA
Firm country
not on file

Where this comes from

Register
FDA Medical Device Recalls (openFDA)
Publisher
U.S. Food and Drug Administration (openFDA)
File
device-recall-0001-of-0001.json.zip
sha256
b87518bfe2e8
Size
288210821 bytes
Published
2026-09-28
Read
2026-09-29T08:25:23.626Z
Source file
Source file retained · verify
Refresh due
2026-10-06

Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Search this register